from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1507c/-

LFCtreatmentdescriptionclass of inhibitor

0.027

Amikacinug/mL Amikacintranslation

-0.181

Cap5-10ug/mL Capreomycintranslation

-1.063

Rox10-50 ug/mL Roxithromycintranslation

0.459

SM2-5 ug/mL Streptomycintranslation

-0.084

Tet5-10 ug/mL Tetracyclinetranslation

0.769

Rif0.2-5ug/mL Rifampicintranscription

0.333

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.401

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.455

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.811

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.166

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.700

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.977

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.899

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.228

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.641

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.392

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.669

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.448

Nigericin50 uM Nigericinrespiration

-0.255

TRC10-150 ug/mL Triclosanrespiration

2.105

TRZ10-25 ug/mL Thioridazinerespiration

-0.460

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.465

menadione6-10 ug/mL Menadionerespiration

-0.335

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.713

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.153

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.408

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.078

NRP_1Non-replicating persistence stage 1dosRassociated

-0.094

Amp0.2mg/mL AmpicillincellWall

0.491

Cephalexin20-100 ug/mL CephalexincellWall

0.547

Cerulenin0.32-5 ug/mL CerulenincellWall

0.644

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.210

EMB10-20 ug/mL EthambutolcellWall

1.041

Eta12-40 ug/mL EthionamidecellWall

0.637

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.056

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.673

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.551

BZA0.12 mg/mL BenzamidearomaticAmides

-0.064

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.418

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.196

H2O24 mM hydrogen peroxideDNAdamaging

0.173

Levo10 ug/mL LevofloxacinDNAdamaging

-0.282

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.149

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.213

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.663

UVUV-irradiationDNAdamaging

0.469

ARP41-4 ug/mL Antitubercular compound ARP4?

0.203

Antimycin12.5-50 ug/mL Antimycin A?

0.000

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.600

PA_110-50 ug/mL Antitubercular compound PA-1?

0.658

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.855

PA8240.2-2 ug/mL PA-824?

-2.320

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.672

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.540

Verapamil50 uM Verapamil?

1.198

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.214

methoxatin10-20 ug/mL Methoxatin?